Long term use of lamotrigine and vigabatrin in severe refractory epilepsy: Audit of outcome

British Medical Journal

Volumn 313, Issue 7066, 1996, Pages 1184-1185

  Walker, M C ^a,c   Sander, J W A S ^b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b EPILEPSY SOCIETY   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; DRUG DERIVATIVE; LAMOTRIGINE; TRIAZINE DERIVATIVE; VIGABATRIN;

ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; EPILEPSY; FOLLOW UP; HUMAN; SURVIVAL RATE; TREATMENT OUTCOME;

CHRONIC DISEASE; CLINICAL TRIALS; EPILEPSY; FOLLOW-UP STUDIES; GAMMA-AMINOBUTYRIC ACID; HUMANS; SURVIVAL RATE; TREATMENT OUTCOME; TRIAZINES; VIGABATRIN;

EID: 0030577195     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.313.7066.1184     Document Type: Article

References (5)

1. Walker MC, Sander JWAS. The impact of new antiepileptic drugs on the prognosis of epilepsy: seizure freedom should be the ultimate goal. AVwrofo£y 1996;46:912-4.
2. Sander JT, Trevisol Binencourt PC, Hart YM, Shorvon SD, Evaluation of vigabatrin as an add-on drug in the management of severe epilepsy. J Neurol Neurosurg Psychiatry 1990;53:1008-10.
3. Sander PJT, Trevisol Bitiencourt PC, Hart YM, Patsalos PN, Shorvon SD. The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy. EpHepyRes 1990;7:226-9.
4. Klenerman P, Sander pSAS, Shorvon SD. Mortality of epilepsy: a study of patients in long-term care. J AVwro/ Neurosurg Psychiatry 1993;56:149-52.
5. Nashef L, Fish DR, Sander JTOS, Shorvon SD. Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre, jf NeurdNeurositrgPsychiatry 1995;58:462-4.